Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
Bioanalysis(1)
Current Pharmaceutical Biotechnology(1)
Drug Metabolism and Drug Interactions(1)
Drug Metabolism and Personalized Therapy(1)
Journal of Pharmacy and Pharmaceutical Sciences(1)
Área temáticas
Farmacología y terapéutica(4)
Medicina y salud(3)
Enfermedades(2)
Fisiología humana(2)
Bioquímica(1)
Área de conocimiento
Farmacología(5)
Química analítica(2)
Diabetes(1)
Laboratorio médico(1)
Medicamento(1)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(6)
ODS 10: Reducción de las desigualdades(2)
ODS 12: Producción y consumo responsables(2)
ODS 17: Alianzas para lograr los objetivos(2)
Origen
scopus(6)
A rapid and simple LC-MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity
ArticleAbstract: Background: The analytical method here reported for the CEIBA cocktail approach has been developed aPalabras claves:Autores:Adrián LLerena, de Andrés F., Sosa-Macías M.G.Fuentes:scopusClinical implementation of pharmacogenetics and personalized drug prescription based on e-health: The MedeA initiative
ArticleAbstract:Palabras claves:Autores:Adrián LLerena, Cobaleda J., de Andrés F., Mata-Martín C., Penãs-Lledó E.M., Pijierro A., Sánchez C.L.Fuentes:scopusCan the CEIBA cocktail designed for human cytochrome P450 enzymes be used in the rat for drug interaction studies?
ArticleAbstract: Purpose - The CEIBA cocktail consisting of caffeine (CAF), omeprazole (OZ), dextromethorphan (DM) anPalabras claves:Autores:Adrián LLerena, Alves G., de Andrés F., Falcao A.C., Magalhães P.Fuentes:scopusHigh-performance liquid chromatography method using ultraviolet detection for the quantification of aripiprazole and dehydroaripiprazole in psychiatric patients
ArticleAbstract: Background: Aripiprazole (ARI) is an antipsychotic drug that is metabolized to dehydroaripiprazole (Palabras claves:Aripiprazole, CYP2D6, Dehydroaripiprazole, High-performance liquid chromatography, Psychiatric patientsAutores:Adrián LLerena, de Andrés F., De la Rubia A., Dorado P., Gonz Ález A., Gonz Ález I., Naranjo M.E.G., Peñ As-Lledó E.Fuentes:scopusPharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients
ArticleAbstract: Mexico has been under official epidemiological alert due to diabetes since 2016. This study presentsPalabras claves:Diabetes type 2, Metformin, pharmacogenetics, sulphonylureas, therapeutic inefficacy, TransportersAutores:Adrián LLerena, de Andrés F., Espinosa-Sánchez A.G., Molina-Guarneros J.A., Ortega-Ayala A., Pérez-Silva E., Rodríguez-Rivera N.S.Fuentes:scopusSimultaneous determination of cytochrome P450 oxidation capacity in humans: A review on the phenotyping cocktail approach
ReviewAbstract: Intra-and/or inter-individual variability in drug response is mainly a result of either subtherapeutPalabras claves:Cocktail, Cytochrome p450, drug metabolism, In vivo, Phenotype, Probe drug, SelectiveAutores:Adrián LLerena, de Andrés F.Fuentes:scopus